DenovAI Biotech
Founded 2023
About DenovAI Biotech
DenovAI is revolutionizing biologics discovery with a Gen AI-Physics platform for the de-novo design of therapeutic proteins, including antibodies and miniproteins. DenovAI’s cutting-edge technology accelerates drug discovery timelines and addressing unmet medical needs with accurately designed molecules.
Company Facts
- Founded: 2023
- Legal name: DenovAI Biotech, Ltd.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: denovai.com
Social Profiles
Canonical: https://fsome.com/organization/denovai-biotech-8362703 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.